《大行報告》瑞銀下調頤海國際(01579.HK)目標價至17元 評級「沽售」
瑞銀髮表評級報告指,頤海國際(01579.HK)去年業績遜預期,其去年銷售額增長11%及純利降22%。該行預料公司在2021年至24年的淨利潤複合年增長率放緩至4.3%(2018至2021年爲14%),以及其淨利潤率將由2021年的12.9%下降至2024年的10.8%。
該行指,考慮到不利第三方銷售因素增加、品牌推廣費用增加,以及經營去槓桿壓力加大,下調公司2022年至24年盈利預測25%至43%,並將其目標價由41.3元下調至17元,維持其評級爲「沽售」。(ca/k)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.